A sizable investor in Allergan doesn't favor the offer Valeant Pharmaceuticals International has made for the Botox maker, in conjunction with activist William Ackman.
from WSJ.com: US Business http://ift.tt/1jXggd8
via IFTTT
from WSJ.com: US Business http://ift.tt/1jXggd8
via IFTTT
No comments:
Post a Comment